Candidate biomarkers were first reported for tumour cells and in the surrounding immune-micro-environment, and include PD-L1 expression,4tumour mutational burden,5,6 presence of lymphoid infiltrates,7, 8, 9and expression levels of interferon (IFN)-γ-inducible genes,10among others. Here, CD274 is linked to neoplasm.